Harvard Management Company’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Harvard Management Company’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-505,871	Closed	-$1.33M	–	22
2020 Q1	$1.33M	Hold	505,871	–	–	0.21%	17
2019 Q4	$597K	Hold	505,871	–	–	0.06%	17
2019 Q3	$870K	Hold	505,871	–	–	0.08%	16
2019 Q2	$2.4M	Hold	505,871	–	–	0.59%	15
2019 Q1	$3.27M	Hold	505,871	–	–	0.83%	13
2018 Q4	$2.54M	Hold	505,871	–	–	0.54%	13
2018 Q3	$4.32M	Hold	505,871	–	–	1.1%	16
2018 Q2	$6.37M	Buy	+505,871	New	+$6.93M	1.51%	10

Harvard Management Company's NTGN Position: Q2 2020 in Review

Harvard Management Company sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 505,871 shares — an estimated $1.33M sold.

Harvard Management Company first reported a position in NTGN in Q2 2018 and held it in 8 quarters. The position peaked at $6.37M in Q2 2018. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Harvard Management Company reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Harvard Management Company sold 505,871 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $1.33M.
Harvard Management Company first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
Harvard Management Company's Neon Therapeutics, Inc. Common Stock position peaked at $6.37M in Q2 2018.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Harvard Management Company's 13F filing for Q2 2020, filed 14 Aug 2020.